Entry Strategies of the Indian Pharma in Africa, Middle-East & CIS
Versandkostenfrei!
Versandfertig in 6-10 Tagen
32,99 €
inkl. MwSt.
PAYBACK Punkte
16 °P sammeln!
The social, economic and demographic context, in which the global pharmaceutical industry functions, is altering. The already developed economies, with escalated healthcare expenses are looking to rein in healthcare disbursements. In developing economies as Africa, C.I.S, & Middle-East the pharmaceutical industries are also undergoing a phase of dynamic change. Rising health consciousness, prevalence of diseases, and healthcare expenditure will help the Middle East & Africa pharma market to grow. To capitalize on the opportunities in the Middle East, CIS & Africa pharma market, the multination...
The social, economic and demographic context, in which the global pharmaceutical industry functions, is altering. The already developed economies, with escalated healthcare expenses are looking to rein in healthcare disbursements. In developing economies as Africa, C.I.S, & Middle-East the pharmaceutical industries are also undergoing a phase of dynamic change. Rising health consciousness, prevalence of diseases, and healthcare expenditure will help the Middle East & Africa pharma market to grow. To capitalize on the opportunities in the Middle East, CIS & Africa pharma market, the multinational companies are looking to penetrate the market through individual or collaborative efforts. Emerging economies as India & China certainly, propose a beam of optimism for the global pharmaceutical industry.......
Andere Kunden interessierten sich für
